We’ve come a long way in continuous glucose monitoring (CGM) technology since it first hit the market over two decades ago, and San Diego-based Dexcom has been leading the way on innovation for most ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results